Select your localized edition:

Close ×

More Ways to Connect

Discover one of our 28 local entrepreneurial communities »

Be the first to know as we launch in new countries and markets around the globe.

Interested in bringing MIT Technology Review to your local market?

MIT Technology ReviewMIT Technology Review - logo

 

Unsupported browser: Your browser does not meet modern web standards. See how it scores »

{ action.text }

Despite its novel technology, Helicos still has some hurdles to overcome. The technology hasn’t yet demonstrated clear advantages over the most sophisticated sequencing machines currently in use. “Single-molecule sequencing has lots of benefits, but it’s very hard from an optics standpoint to detect a single molecule on a piece of DNA,” says Mardis. Because of this, the Helicos machine is much more expensive than the alternatives.

“We’re still a little underwhelmed,” says George Weinstock, associate director of the Genome Sequencing Center at Washington University. “Right now, I would say it’s a wash, in terms of time and cost. I would say they’re a couple of years out from having an impact.”

Still, the advance is “a pretty big accomplishment,” says Jeff Schloss, director of the Genome Technology Program at the National Human Genome Research Institute in Bethesda, MD. “It’s important to get these results in the peer-reviewed literature.” Some scientists have criticized a series of impressive but unpublished sequencing claims, saying it’s too difficult to evaluate them without having detailed information on the methodology.

Helicos is soon likely to face another slew of competitors. Development of so-called “third generation” sequencing technologies is already under way–these systems aim to sequence a single molecule of DNA in real time, boosting speed and reducing the amount and cost of chemicals used in the process.

Helicos is also moving forward rapidly. The technology used in the Science paper has already been replaced in the company’s commercial device, improving on some faults described in the paper, such as difficulty reading certain repetitive sequences.Says Timothy Harris, senior director of research at Helicos and lead author on the paper, “Things change faster than you can publish them.”

3 comments. Share your thoughts »

Credit: Technology Review

Tagged: Biomedicine, sequencing, genomics, $1000 genome, Helicos

Reprints and Permissions | Send feedback to the editor

From the Archives

Close

Introducing MIT Technology Review Insider.

Already a Magazine subscriber?

You're automatically an Insider. It's easy to activate or upgrade your account.

Activate Your Account

Become an Insider

It's the new way to subscribe. Get even more of the tech news, research, and discoveries you crave.

Sign Up

Learn More

Find out why MIT Technology Review Insider is for you and explore your options.

Show Me